Company: MDXG
Filing Date: 2025-02-26
Form Type: 10-K
Source: 0001376339-25-000009
Chunk: 38

Company: MIMEDX GROUP, INC.
Filing Date: 2025-02-26
Form: 10-K
Item: Item 8
Chunk 38
---
 expense related to the ESPP. As of December 31, 2024 and 2023, the Company had cumulative payroll deferrals under the ESPP for future share purchases of $0.6 million and $0.7 million, respectively. This amount is included in accrued compensation in the consolidated balance sheet.Unrecognized stock compensation for the period is less than $0.1 million to be recognized over a weighted average period of 0.08 years.

Share Withholding for Employee TaxesRepurchases of shares of Common Stock in connection with the satisfaction of employee tax withholding obligations upon vesting of restricted stock and exercise of stock options for the years ended December 31, 2024, 2023, and 2022 were 354,263, 0, and 249,442, respectively, for an aggregate purchase price of $2.6 million, $0, and $1.2 million, respectively.

12.     Revenue

Net Sales By Product CategoryMIMEDX has two product categories: (1) Wound, which reflects products typically used in Advanced Wound Care settings, including the treatment of chronic, non-healing wounds, and (2) Surgical, which reflects products principally used in surgical settings, including the closure of acute wounds or the protect and reinforce tissues and/or regions of interest. The Company manages its product portfolio and pipeline based upon opportunities in each of these settings.

F- 30

Below is a summary of net sales by product line (in thousands):Year Ended December 31,202420232022Wound$231,004 $205,660 $175,970 Surgical117,875 115,817 91,871 Total$348,879 $321,477 $267,841 The Company did not have significant foreign operations or a single external customer from which 10% or more of revenues were derived during the years ended December 31, 2024, 2023, or 2022.

Net Sales By Care SettingMIMEDX has three sites of service for its products (1) Hospital settings and wound care clinics, which are stable reimbursement settings in which products are used for both wound and surgical applications, (2) Private offices, which generally represents doctors and practitioners with independent operations, and (3) Other, which includes federal facilities, international sales, and other sites of service.Below is a summary of net sales by site of service (in thousands):Year Ended December 31